Illumina expands Billion Cell Atlas program with new AI drug developers
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
| Illumina, Inc. (NASDAQ: ILMN) | Delayed: 264.57 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $264.57 | 52 Week High | $196.47 | |||
| Open | $264.57 | 52 Week Low | $127.10 | |||
| Day High | $264.57 | P/E | 293.97 | |||
| Day Low | $264.57 | EPS | $0.90 | |||
| Volume | 241 | |||||
